Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

46.02
Delayed Data
As of Aug 21
 -0.14 / -0.30%
Today’s Change
42.23
Today|||52-Week Range
69.85
-24.08%
Year-to-Date
No recent news for ANI Pharmaceuticals Inc.

Today’s Trading

Previous close46.16
Today’s open46.02
Day’s range45.50 - 46.95
Volume50,802
Average volume (3 months)122,276
Market cap$537.2M
Dividend yield--
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)-74.24%
Earnings growth (this year)+1.59%
Earnings growth (next 5 years)+18.20%
Revenue growth (last year)+68.53%
P/E ratio102.3
Price/Sales5.45
Price/Book3.16

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc+0.25+4.16%
SYRSSyros Pharmaceutical...-0.75-3.72%
NTLAIntellia Therapeutic...+1.59+10.49%
MCRBSeres Therapeutics I...-0.13-1.00%
Data as of 08/21/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.99
Annual revenue (last year)$128.6M
Annual profit (last year)$3.9M
Net profit margin3.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts